Organic CBD rich cannabis oil
Cannabinoid (CBD oil), hemp oil, recreational cannabis and medicinal cannabis are all derived from separate varieties of the same plant – cannabis sativa. It contains are over a 100 phytocannabiols including delta-9-tetrahydrocannabinol (THC) which has the psychotropic (high) effects. Scientists are particularly interested in the biologically properties of cannabidiol (CBD). So far, it has been discovered that CBD has anti-inflammatory, anti-convulsant, anti-psychotic, anti-oxidant, neuroprotective and immune support effects. CBD is not intoxicating and hence is completely legal .
Why Organic CBD rich cannabis oils?
The extraction process is very important to preserve the functions we know about and the ones we are yet to discover. Likewise, the if the oil is contaminated with pesticides, herbicides and other toxins its potential heath benefits are likely to be mitigated. Furthermore, when the oil is extracted by cold pressing, it preserves the other nutrients such as the omega 3 and 6 fatty acids, vitamin E and other phytochemicals which have numerous reported health benefit.
Why NatureMedical CBD oils?
Naturemedical specialises in highly purified natural products which have pharmaceutical grade quality assurance. Our organic CBD rich cannabis oils were extracted by gently steaming then cold pressing the organically nurtured cannabis sativa plants to protect their unique bioactive properties. You can be reassured that our oils have full authenticity, free from pesticides and herbicides and the cannabinoids are fully functional.
What the experts say
Here is what Professor Robert Thomas, a leading consultant oncologist and expert in functional and nutritional medicine says about our products:
” The emerging evidence for the biological properties of cannabinoids are intriguing and as the barriers for research are being lifted, no doubt, their benefits will be clarified. If you are interesting in taking CBD as a nutritional supplement to support a healthy lifestyle it is vital that you chose one which has been extracted via a process which preserves its function and is not contaminated by toxins. NatureMedical’s organic CBD rich cannabis oil certainly meets these criteria”
The evidence so far for medicinal cannabis, recreational cannabis and CBD nutritional supplements have been reviewed carefully so please read before considering using these products. The level of THC is the maximum legal allowed in every batch (<0.2%).
Everybody’s system is different, so an effective dose varies. Some individual’s will find relief with 3mg twice a day, while others are closer to 200mg four times a day or higher!
Start low and work up: The best way to find a proper dosage is to start low and slow and keep adjusting. For those new to CBD oils, maybe try dosing at 5mg as needed to maintain relief. If multiple doses were taken during the first day, adjust the dose to 10mg and take note to any changes in effect. Keep adjusting as needed until relief is consistent. For those more experienced with cannabis, they may want to start at a higher dose, like 25mg, and adjust from there.
Background information about medicinal cannabis
As mentioned above CBD oils are nutritional supplements to support a healthy lifestyle. Although legal, they are not medicines and cannot be prescribed by a medical practitioner.
A clear definition of what constitutes a cannabis derived medicinal product has been developed by the Department for Health and Social Care for England and the UK Medicines and Health Products Regulatory Agency (MHRA), and only products meeting this definition have been rescheduled under the UK’s misuse of drugs legislation – otherwise the director of these companies will have ended up in jail. Synthetic cannabis has had medical licence 1982, phytocannabinoids gained a licence in the autumn of 2018 largely due to the research and development efforts of the UK pharmaceutic company GWpharma. All other THC containing products remain illegal in the UK and many other countries.There are numerous ongoing studies in progress which may gain medical licenses in the future but the indications for medicinal product so far include:
Nausea: Dronavinol and nabilone both containing man-made delta-9-THC, are approved for cancer related nausea. A Cochrane meta-analysis of 23 subsequent randomized RCT’s reviewed studies showed that, either as on their own or in combination with other anti-emetics, individuals were more likely to report complete absence of nausea and vomiting when they received these cannabinoids compared with placebo. Participants were, however, more likely to withdraw from the studies because of an adverse event such as sedation, or drowsiness, dizziness, dysphoria or depression, hallucinations, paranoia or hypotension. Since these studies newer very effective anti-emetics are available such as ondansetron and aprepitant which have less side effects. Their role is now only relevant if these medications fail.
Multiple sclerosis: Sativex is an oromucosal spray of extract of the cannabis sativa plant that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 1:1 ratio as well as specific minor cannabinoids and other non-cannabinoid components. It is administered as an oromucosal spray, and has received regulatory approval in 21 countries to help relieve muscle pasticity, spasms, bladder dysfunction and pain symptoms associated with multiple sclerosis.
Epilepsy: Epidiolex, gained a medical license for the treatment of some rare epilepsies associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. It contains a mixture of THC and CBD.
Conditions under investigation (not yet licensed)
Appetite stimulation: Small studies have shown cannabis increased appetite in patients with AIDs compared to placebo. Three other studies have showed it was slightly inferior to progesterone called megestrol another appetite stimulator but did not have the fluid retention properties. Trials conducted in the 1980s involved healthy control subjects, inhaling cannabis and reported an increased caloric intake although they did not educate or prepare participants so most of these calories were via sweet and fatty foods.
Analgesia, anxiety and sleep disorders: One small study reported that cannabinoids were associated with substantial analgesic effects, with anti-emetic effects, relaxation benefits and appetite stimulation. In a follow up study, 10 mg doses of cannabis produced analgesic effects for 7 hours comparable to 60 mg doses of codeine. Another study reported that patients who used nabilone experienced improved management of pain, nausea, anxiety, increased quality of sleep and relaxation when compared with untreated patients, resulting in decreased use of opioids, anti-inflammatory drugs, anti-depressants, gabapentin and anti-sickness drugs. Patients often experience mood elevation after exposure to cannabis and depending on their previous experience could be positive or negative. A small study of inhaled cannabis reported that patients who self-administered Cannabis had improved mood, improved sense of well-being, better sleep patterns and less anxiety.
Peripheral neuropathy (neuropathic pain): Two RCT’s of inhaled cannabis in patients with peripheral neuropathy or neuropathic pain of various aetiologies found that pain was reduced compared with those who received placebo. Two additional trials of inhaled cannabis have also demonstrated a benefit over placebo in HIV-associated neuropathic pain.
Other medical conditions: Ongoing studies are investigating the anti-inflammatory and antioxidant properties of cannabis for conditions such as arthritis, cancer and dementia. No significant results have yet been published from statistically robust trials – read the recent review of the data